Reportedly, fascin overexpression was associated with worse survival of the patients with lung cancer, small intestinal carcinoma, laryngeal squamous cell carcinoma, HCC, oral squamous carcinoma, breast cancer, and ESCC [29, 30, 36, 41, 43, 45, 46]. This evidence concerns the gene FSCN1 and small intestine carcinoma.